AURO-SILODOSIN

Identification of Auro-Silodosin

No description

Google image searchProduct monograph

Active ingredient

silodosin, 4 MG

DIN: 02478501

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: AURO PHARMA INC

Date: 16-FEB-2022

ATC:

• G04 — UROLOGICALS (ATC, ATC/DDD, )
• G04C — DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY (ATC, ATC/DDD)
• G04CA — Alpha-adrenoreceptor antagonists (ATC, ATC/DDD)
• G04CA04 — SILODOSIN (ATC/DDD)

Reference brand drug: Rapaflo

Pharmaceutical standard: MFR

External Links for Auro-Silodosin

Search on Google

• Auro-Silodosin side effects
• Auro-Silodosin dosage
• silodosin side effects
• silodosin dosage

Auro Pharma Inc

Go to Auro Pharma website to see drug product details. Sometimes you can find auro-silodosin photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.